Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q4 2019 Results - Earnings Call Transcript

Feb. 24, 2020 10:15 PM ETRevance Therapeutics, Inc. (RVNC)
SA Transcripts profile picture
SA Transcripts

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2019 Results Earnings Conference Call February 24, 2020 4:30 AM ET

Company Participants

Jeanie Herbert - Senior Director of Investor Relations and Corporate Communications

Mark Foley - President, Chief Executive Officer

Dustin Sjuts - Chief Commercial Officer of Aesthetics & Therapeutics

Toby Schilke - Chief Financial Officer

Abhay Joshi - Chief Operating Officer, President of R&D and Product Operations

Conference Call Participants

Annabel Samimy - Stifel

Ken Cacciatore - Cowen and Company

Holly Barra - Goldman Sachs

David Amsellem - Piper Sandler

Balaji Prasad - Barclays

Tim Lugo - William Blair

Seamus Fernandez - Guggenheim

Dan Clarke - Mizuho Securities

Serge Belanger - Needham & Company


Welcome to the Revance Therapeutics fourth quarter and full year 2019 financial results and corporate update conference call. At this time, all participants are in a listen-only mode. Following managements' prepared remarks, we will hold a Q&A session. [Operator Instructions]. As a reminder, this call is being recorded today, February 24, 2020.

I would now like to turn the conference call over to Jeanie Herbert, Senior Director of Investor Relations and Corporate Communications for Revance. Please go ahead.

Jeanie Herbert

Thank you Jewel. Joining us on the call today from Revance is President and Chief Executive Officer, Mark Foley, Chief Financial Officer, Toby Schilke, Chief Operating Officer and President of R&D and Product Operations, Dr. Abhay Joshi, Chief Commercial Officer, Aesthetics and Therapeutics, Dustin Sjuts.

Earlier today, Revance released financial results for the fourth quarter and full year ended December 31, 2019. If you have not received this news release or would like to be added to the company's distribution list to receive future releases, please go to the Investor Relations section of Revance's website, which can be found at

During this conference call, management will make forward-looking

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.